This Article
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faris, P. M.
Right arrow Articles by Valeri, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faris, P. M.
Right arrow Articles by Valeri, C. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?

The Journal of Bone and Joint Surgery, Vol 73, Issue 8 1169-1178, Copyright © 1991 by Journal of Bone and Joint Surgery, Inc


JOURNAL CONTENTS

Unwashed filtered shed blood collected after knee and hip arthroplasties. A source of autologous red blood cells

PM Faris, MA Ritter, EM Keating and CR Valeri
Center for Hip and Knee Surgery, Mooresville, Indiana 46158.

We evaluated the results of twelve hematological and plasma protein determinations in 450 to 500-milliliter volumes of shed blood that had been collected with or without acid-citrate-dextrose anticoagulant (National Institutes of Health Formula A) from knees and hips during the first twelve hours after arthroplasty. We also evaluated the effects on the recipients when the blood was used for reinfusion. The findings in the units that had been obtained in less than four hours, in between four and six hours, and in more than six hours after the arthroplasty were similar whether or not the acid-citrate-dextrose anticoagulant had been used. The mean values for the collected units were: in the blood, a concentration of hemoglobin of 115 grams per liter, a hematocrit of 0.34, a white blood-cell count of 4.8 x 10(9) per liter, and a red blood-cell count of 3.7 x 10(12) per liter, and, in the plasma, a level of hemoglobin of 160 grams per liter, a level of fibrinogen of less than 0.2 gram per liter, a level of factor-V clotting protein of less than 10 per cent of normal, a level of factor-VIII clotting protein that was 45 per cent of normal, a level of antithrombin III that was 45 per cent of normal, a level of plasminogen that was 55 per cent of normal, a level of protein C that was 100 per cent of normal, and a level of fibrin-degradation products of 1000 micrograms per milliliter of plasma. The clinical response of the patient was assessed after the reinfusion of a total of 205 units of unwashed shed blood into 153 patients. In addition, in 126 of the 153 patients, hematological and plasma-protein measurements were analyzed before the autotransfusion and one and twenty-four hours afterward. Each of these patients had received one to four units of shed blood that had been filtered but not washed. Only two (2 per cent) of the ninety-nine patients who received shed blood that had been collected six hours or less after the operation had a febrile reaction, whereas twelve (22 per cent) of the fifty-four patients who received blood that had been collected six to twelve hours after the operation had such a reaction.(ABSTRACT TRUNCATED AT 400 WORDS)
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Am Acad Orthop SurgHome page
E. M. Keating and J. B. Meding
Perioperative Blood Management Practices in Elective Orthopaedic Surgery
J. Am. Acad. Ortho. Surg., November 1, 2002; 10(6): 393 - 400.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
J. A. Salido, L. A. Marin, L. A. Gomez, P. Zorrilla, and C. Martinez
Preoperative Hemoglobin Levels and the Need for Transfusion After Prosthetic Hip and Knee Surgery : Analysis of Predictive Factors
J. Bone Joint Surg. Am., February 1, 2002; 84(2): 216 - 220.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
C. W. Colwell Jr., E. Beutler, C. West, M. E. Hardwick, and B. A. Morris
Erythrocyte Viability in Blood Salvaged During Total Joint Arthroplasty with Cement
J. Bone Joint Surg. Am., January 1, 2002; 84(1): 23 - 25.
[Abstract] [Full Text]


Home page
NEJMHome page
L. T. Goodnough, M. E. Brecher, M. H. Kanter, and J. P. AuBuchon
Transfusion Medicine -- Blood Conservation- Second of Two Parts
N. Engl. J. Med., February 18, 1999; 340(7): 525 - 533.
[Full Text] [PDF]


Home page
JBJSHome page
E. M. KEATING
Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Current Options and Approaches for Blood Management in Orthopaedic Surgery*{{dagger}}
J. Bone Joint Surg. Am., May 1, 1998; 80(5): 750 - 62.
[Full Text]


Home page
JBJSHome page
M. J. LEMOS and W. L. HEALY
Current Concepts Review - Blood Transfusion in Orthopaedic Operations
J. Bone Joint Surg. Am., August 1, 1996; 78(8): 1260 - 71.
[Full Text]


Home page
American Journal of Medical QualityHome page
L. T. Goodnough, M. S. Bodner, and J. W. Martin
Blood Transfusion and Blood Conservation: Cost and Utilization Issues
American Journal of Medical Quality, December 1, 1994; 9(4): 172 - 183.
[Abstract] [PDF]